Sr. Director, Clinical Quality Assurance

Company Overview

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double‑stranded breaks in the DNA.

This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values‑driven organization committed to its people, cutting‑edge science, and a vision of providing life‑long cures to patients suffering from serious diseases.

The Sr. Director, Clinical Quality Assurance will act as a leader in the Quality organization and will be responsible for the quality oversight for Beam’s clinical trials and overall GCP (Good Clinical Practice). The position will be critical to the overall strategy and growth of the Quality organization for Beam as the company grows and evolves from Development to a Commercial organization in preparation for licensure.

Reporting to the VP, Compliance, the position will be a key liaison with the Clinical Operations team, Clinical Development, Medical and Safety teams, programs teams, regulatory, and others back to the Quality organization. The position will take a leadership role responsible for developing and overseeing a company's global clinical quality assurance strategy to ensure compliance with regulations like Good Clinical Practice (GCP).

Key duties include managing audits and inspections, implementing quality management systems, reviewing study documentation, and leading a high‑performing team. This position requires extensive experience in a quality assurance role, often with a background in life sciences and strong leadership skills.

The Director/Sr. Director of Clinical GCP Quality will be responsible for designing, delivering and executing the global clinical quality assurance strategy. Ensure clinical trials and research activities are compliant with GCP, FDA, ICH, and other international regulations and laws. Review and approve study‑related documents, such as protocols, investigator brochures, and informed consent forms. Mentor and manage a high‑performing CQA team. Collaborate with internal teams and engage with regulatory bodies and industry groups.

The position will have overall responsibility to ensure initiatives related to clinical quality and compliance are optimized and executed appropriately.

• Strategy and oversight:
  Design, deliver, and execute the global Clinical Quality Assurance (CQA) strategy.
• Compliance:
  Ensure clinical trials and research activities are compliant with GCP, FDA, ICH, and other international regulations and laws.
• Audits and inspections:
  Conduct complex internal audits and external inspections of clinical sites, vendors, and internal processes.
• Quality management:
  Oversee the quality management system and drive initiatives for continuous improvement.
• Documentation:
  Review and approve study‑related documents, such as protocols, investigator brochures, and informed consent forms.
• Leadership:
  Build, mentor, and manage a high‑performing CQA team.
• Stakeholder engagement:
  Collaborate with internal teams and engage with regulatory bodies and industry groups.
• Lead the clinical quality assurance group and help define and drive the Clinical Quality Assurance and compliance vision and mindset in close collaboration with the Clinical Operations and Clinical Development leads.
• Define clear clinical quality assurance objectives and ensure progress and cross‑functional completion of responsibilities; use judgment to develop solutions, drive risk analysis and mitigation strategies.
• Develop a risk based GCP compliance program and implement at Beam to enable clinical programs to progress through the clinical trials, per ICH E6 R3 guidance and global regulations.
• Ensure…